0001610717-24-000165.txt : 20240318
0001610717-24-000165.hdr.sgml : 20240318
20240318192702
ACCESSION NUMBER: 0001610717-24-000165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240318
DATE AS OF CHANGE: 20240318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eckburg Paul
CENTRAL INDEX KEY: 0001914512
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 24760630
MAIL ADDRESS:
STREET 1: 1785 WOODHAVEN PLACE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AN2 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001880438
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 820606654
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
BUSINESS PHONE: (650) 331-9090
MAIL ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
4
1
form4.xml
X0508
4
2024-03-15
0001880438
AN2 Therapeutics, Inc.
ANTX
0001914512
Eckburg Paul
C/O AN2 THERAPEUTICS, INC.
1800 EL CAMINO REAL, SUITE D
MENLO PARK
CA
94027
true
Chief Medical Officer
false
Common
2024-03-15
4
A
0
30000
0
A
51416
D
Stock Option (right to buy)
3
2024-03-15
4
A
0
60000
0
A
2034-03-14
Common Stock
60000
60000
D
These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Reflects the adjusted total which includes the purchase of 3,127 shares under the AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan on March 31, 2023.
The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
/s/ Lucy Day, Attorney-in-Fact for Paul Eckburg
2024-03-18